Value-Based Care Guide

Value-Based Care Requirements for Addiction Treatment Programs

A detailed guide to meeting HEDIS quality measures, outcome tracking requirements, and documentation standards to maximize value-based care bonuses in substance use disorder treatment. Updated for 2026 payer contracts.

12 min read
Updated April 2026
HiBoop

What is Value-Based Care in Addiction Treatment?

Value-based care (VBC) shifts payment from traditional fee-for-service (volume-based) to performance-based reimbursement tied to patient outcomes, quality measures, and cost efficiency. For addiction treatment programs, this means:

  • Quality bonuses: Additional payment for meeting HEDIS measures, outcome targets, and readmission goals
  • Outcome accountability: Demonstrating clinical improvement using validated assessments
  • Cost efficiency: Reducing readmissions, ED visits, and unnecessary hospitalizations
  • Patient engagement: Tracking treatment initiation, engagement, and post-discharge follow-up
  • Potential Financial Impact

    Addiction treatment programs meeting VBC requirements can earn performance bonuses, depending on size, payer mix and contract terms.

Key HEDIS Measures for Addiction Treatment

  • HEDIS (Healthcare Effectiveness Data and Information Set) measures are standardized quality metrics used by most Medicaid managed care plans and commercial payers. Addiction treatment programs must meet these benchmarks to qualify for VBC bonuses:

  • 1. Initiation and Engagement of Treatment (IET)

    Measures: Percentage of patients who initiate treatment within 14 days of diagnosis AND engage in treatment within 34 days.

    MetricRequirementTarget
    InitiationInpatient admission or outpatient visit within 14 days≥75%
    Engagement2+ additional services within 34 days of initiation≥50%
  • 2. Follow-Up After ED Visit (FUM/FUA)

    Measures: Percentage of patients who receive follow-up after emergency department visit for mental health or substance use.

    • 7-day follow-up (FUM-7): Contact within 7 days of ED discharge (target: ≥70%)
    • 30-day follow-up (FUM-30): Contact within 30 days of ED discharge (target: ≥85%)
    • Qualifying activities: Outpatient visit, telehealth session, phone assessment, case management contact
  • 3. Depression Screening and Follow-Up (DSF)

    Measures: Percentage of patients screened for depression using a standardized tool (PHQ-9 required) AND have documented follow-up plan if screen is positive.

    • Screening requirement: PHQ-9 administered at intake (target: ≥85%)
    • Follow-up requirement: Treatment plan documented if PHQ-9 ≥10 (target: ≥100%)
    • Timeframe: Must occur during index visit or within 7 days
  • 4. Unhealthy Alcohol Use Screening (ASF)

    Measures: Percentage of patients screened for unhealthy alcohol use using AUDIT or AUDIT-C AND receive brief intervention if screen is positive.

    • Screening requirement: AUDIT or AUDIT-C at intake (target: ≥85%)
    • Intervention requirement: Brief intervention or treatment referral if AUDIT ≥8 (target: ≥100%)

Outcome Tracking Requirements

Beyond HEDIS measures, most VBC contracts require demonstrating clinical improvement using validated assessments. This is often the largest component of VBC bonuses.

Required Assessment Tools

AssessmentPurposeAdministration ScheduleImprovement Target
PHQ-9Depression severityIntake, discharge, 30/60/90-day follow-up≥5-point reduction
GAD-7Anxiety severityIntake, discharge, 30/60/90-day follow-up≥5-point reduction
AUDITAlcohol use severityIntake, discharge, 30/60/90-day follow-up≥4-point reduction
DAST-10Drug use severityIntake, discharge, 30/60/90-day follow-up≥3-point reduction
PCL-5PTSD symptoms (if indicated)Intake, 60-day follow-up≥10-point reduction

Calculating Improvement Rates

Most VBC contracts require aggregate improvement rates across your patient population:

  • Example Calculation

    Program with 150 patients completing treatment in Q1 2026:

    • 78 patients achieved ≥5-point reduction on PHQ-9 (52% improvement rate)
    • 85 patients achieved ≥5-point reduction on GAD-7 (57% improvement rate)
    • 92 patients achieved ≥4-point reduction on AUDIT (61% improvement rate)

    VBC Bonus Trigger: Most contracts pay bonuses if ≥50% of patients achieve clinically significant improvement.

Readmission and Retention Metrics

Payers increasingly tie bonuses to cost efficiency metrics, particularly readmission rates:

MetricDefinitionTarget
30-Day Readmission Rate% of patients readmitted within 30 days of discharge≤15%
90-Day Readmission Rate% of patients readmitted within 90 days of discharge≤35%
Treatment Completion Rate% of patients completing recommended length of stay≥70%
30-Day Abstinence Rate% of patients abstinent at 30-day follow-up≥60%

Documentation Requirements

  • VBC audits are common. Ensure your documentation meets these standards:

  • Required Documentation

    • Assessment scores in clinical notes with dates
    • Baseline (intake) and follow-up scores documented
    • Treatment plans referencing assessment results
    • Follow-up contact logs (dates, methods, outcomes)
    • Aggregate outcome reports for program-level data
    • Data export in payer-required format (CSV, HL7, API)
  • Audit Failure Risks

    • Missing assessment scores (incomplete data)
    • Inconsistent administration schedule
    • No documented follow-up after positive screens
    • Unable to demonstrate outcome improvement
    • Handwritten scores without date/time stamps
    • Inability to produce aggregate reports on demand

Maximizing VBC Bonuses: Best Practices

1. Automate Data Collection

  • Digital scoring: Eliminate manual calculation errors and improve scoring accuracy for audits
  • Clinical alerts: Immediate notification for high-risk patients ensures documented follow-up
  • Scheduled reminders: Email schedules send post-discharge assessments on schedule, so follow-up does not depend on someone remembering
  • EHR integration: HL7/FHIR sync ensures assessment scores appear in clinical notes without re-entry

2. Implement Consistent Protocols

  • Sample Assessment Protocol

    Time PointRequired AssessmentsCompletion Target
    IntakePHQ-9, GAD-7, AUDIT, DAST-10100%
    Weekly (IOP)PHQ-9, GAD-7, AUDIT, DAST-10≥90%
    ReviewPHQ-9, GAD-7, AUDIT, DAST-10≥95%
    30-Day Follow-UpPHQ-9, GAD-7, AUDIT, DAST-10≥85%
    60-Day Follow-UpPHQ-9, GAD-7≥75%
    90-Day Follow-UpPHQ-9, GAD-7≥70%

3. Train Staff on VBC Requirements

  • Educate clinicians on HEDIS measures and documentation requirements
  • Establish workflows for responding to clinical alerts (PHQ-9 item 9, high-risk scores)
  • Create internal audit processes to identify documentation gaps before payer audits
  • Celebrate VBC bonus achievements to maintain staff engagement

Common VBC Implementation Challenges

  • Challenge: Low post-discharge follow-up completion rates

    Solution: Implement automated email assessments at 30/60/90 days. Scheduled reminders keep follow-up consistent and produce the documentation HEDIS FUM reporting needs.

  • Challenge: Manual scoring errors and inconsistent administration

    Solution: Digital scoring eliminates manual calculation errors and ensures consistent administration. Clinical alerts prevent missed high-risk patients (suicidal ideation, severe symptoms), improving patient safety and audit compliance.

  • Challenge: Unable to produce aggregate outcome reports for payer submission

    Solution: Use measurement-based care platforms with built-in reporting dashboards. Export data in payer-required formats (CSV, HL7) with one click instead of manual spreadsheet compilation.

Financial Impact: How Bonuses Are Earned

  • How a VBC bonus is typically structured

    Example Treatment Centre (illustrative) A residential and IOP program is usually measured on:

    • HEDIS depression screening compliance against the contract target
    • Documented outcome improvement rate against the contract threshold
    • 30-day readmission rate compared with the program's baseline

    Bonus amounts are set by each payer contract.

    Weigh the bonuses in your own contracts against your platform cost. Returns vary by contract and are not guaranteed.

Key Takeaways

  • HEDIS measures (IET, FUM, DSF, ASF) require ≥85% compliance for VBC bonuses

  • Outcome tracking with validated tools (PHQ-9, GAD-7, AUDIT, DAST-10) is critical

  • Automated delivery and reminders make it easier to collect assessments at every required time point

  • Documentation must be audit-ready: scores in notes, follow-up documented, aggregate reports available

  • Bonus size depends on program size, payer mix, and contract terms

  • The return on an MBC platform depends on your contracts; model it with your own numbers before you commit

Put these insights into practice

Frequently Asked Questions

  • What are the main value-based care requirements for addiction treatment programs?

    Key VBC requirements include: (1) HEDIS quality measures - depression screening (PHQ-9), follow-up after ED visit for mental health/SUD, initiation and engagement of treatment; (2) Outcome tracking - documented improvement on validated assessments (AUDIT, DAST-10, PHQ-9, GAD-7); (3) Readmission reduction - 30-day and 90-day readmission rates; (4) Treatment completion rates; (5) Post-discharge follow-up documentation. Most contracts require 85%+ compliance on screening measures and demonstrable clinical improvement for VBC bonuses.

  • What HEDIS measures apply to substance use disorder treatment?

    Key HEDIS measures for SUD treatment include: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET), Follow-Up After Emergency Department Visit for Mental Illness or Substance Use Disorder (FUM/FUA), Depression Screening and Follow-Up (DSF), Unhealthy Alcohol Use Screening and Follow-Up (ASF). Requirements typically mandate 85% screening compliance and documented follow-up within specified timeframes (7 days for post-ED, 14 days for initiation, 34 days for engagement).

  • How do I demonstrate clinical improvement for value-based care bonuses?

    Use validated assessments (AUDIT, DAST-10, PHQ-9, GAD-7) at baseline and follow-up to document change scores. Most payers define "clinically significant improvement" as: ≥5-point reduction on PHQ-9 or GAD-7, ≥4-point reduction on AUDIT, ≥3-point reduction on DAST-10. Calculate aggregate improvement rates for your program (e.g., "52% of patients achieved clinically significant improvement on depression scores"). Digital outcome tracking systems ensure consistent data collection and reporting.

  • What documentation is required for value-based care audits?

    VBC audits typically require: (1) Assessment scores documented in clinical notes with dates, (2) Baseline scores at intake and follow-up scores at discharge/follow-up, (3) Treatment plans that reference assessment results, (4) Follow-up contact documentation (dates, methods, outcomes), (5) Aggregate outcome reports showing program-level improvements. Store data in a format compatible with payer submission requirements (CSV, HL7, or API integration). Incomplete or missing documentation can result in bonus recoupment.